IMPORTANCE Fear of dementia is pervasive in older people with cognitive concerns. Much research is devoted to finding prognostic markers for dementia risk. Studies suggest apathy in older people may be prodromal to dementia and could be a relevant, easily measurable predictor of increased dementia risk. However, evidence is fragmented and methods vary greatly between studies.
F ear of dementia is common in patients presenting to memory clinics with cognitive concerns. 1 Although clinical evaluation can lead to a dementia diagnosis, patients often have milder conditions, including mild cognitive impairment (MCI) and isolated subjective cognitive concerns (SCC).
2-4 The annual progression from MCI to dementia in clinical settings is about 5% to 15%, while 20% to 25% of patients revert to normal cognition and functioning. 5 Patients with SCC have an increased risk (1.5-to 3-fold) of developing dementia compared with individuals without cognitive concerns, but most do not develop dementia in the near future. 3 However, fear of dementia is pervasive in patients with SCC or MCI, 1 and identifying those at increased risk is an important clinical concern.
Apart from memory loss and other cognitive disturbances, behavioral symptoms are common in most occurring forms of late-life dementia including Alzheimer disease (AD) and vascular dementia. 6 One of the most prevalent behavioral symptoms is apathy, estimated to affect almost half of patients. 7 Apathy is a disorder of motivation, manifesting itself as reduced interest, goal-directed cognition, and emotional expression. 8 Apart from dementia, apathy also occurs in MCI 9 and community-dwelling older people. 10 It has high clinical relevance because patients with apathy tend to withdraw from care and may escape clinicians' attention.
11-14
Apathy has been associated with incident dementia and could be useful as an easily assessable, low-cost, noninvasive marker of increased risk, which is relatively common and specific for future cognitive decline compared with other neuropsychiatric symptoms. 10,15-17 However, evidence is fragmented and apathy definitions vary greatly between studies. 10 We aimed to systematically review and meta-analyze the evidence from longitudinal cohorts for the association between apathy in older people and the risk of incident dementia.
Methods
In this systematic review and meta-analysis following PRISMA and MOOSE guidelines, 18 we collated longitudinal cohort studies assessing apathy and subsequent incident dementia. Study populations could involve the general community-dwelling population or memory clinic patients. Studies concerning participants selected for specific medical conditions (eg, Down syndrome or frailty) or patients from care settings were excluded because such conditions may modify the association between apathy and incident dementia. Authors could use any diagnostic criteria to define apathy and dementia, provided definitions were clearly specified. Given the difficulties of retrospectively assessing whether apathy symptoms preceded dementia, only prospective cohort studies that diagnosed apathy in individuals without dementia were included. Randomized clinical trials were excluded because interventions provided may influence the association between apathy and incident dementia. There were no restrictions on publication year, language, or length of follow-up. There was no registered predefined review protocol.
Medline, Embase, and PsychINFO databases were searched from inception to October 2, 2017, and deduplicated using the OVID platform. 19 The full search is listed in eTable 1 in the Supplement. Search terms included apathy and commonly used apathy assessment instruments, 20 cross referenced with dementia or AD and terms referring to risk, incident, or prediction. Two investigators (L.vW. and J.W.vD.) independently screened titles and abstracts for (1) prospective longitudinal studies published in peer-reviewed journals; (2) in unselected community-dwelling populations or nondemented populations with cognitive concerns with or without cognitive impairment; (3) that clearly defined apathy and dementia diagnoses; and (4) that reported data regarding the association between apathy and incident dementia. Conflicts regarding inclusion were resolved by consensus. Full texts and bibliographies of included studies and relevant reviews were hand searched for additional studies. Data were extracted by 1 reviewer (J.W.vD.) and checked by a second (L.vW.) using a piloted standardized extraction form (eTable 2 in the Supplement) and assessed for risk of bias using an adapted version of the Newcastle-Ottawa quality assessment scale for cohort studies. 21 Risk ratios (RR) and 95% confidence intervals for incident dementia were calculated per study using the number of dementia cases in the apathy and nonapathy groups. If unavailable, authors were approached to supplement these data. 22 If both AD and all-cause dementia were available, 23, 24 all-cause dementia was used. A sensitivity analysis used AD as preferred outcome. Risk ratios, reported odds ratios (OR), and reported hazard ratios (HR) were pooled separately across studies. Random-effects Der Simonian-Laird models were used because of the heterogeneous study characteristics.
25
P values were 2-sided. For pooling reported effect sizes, maximally adjusted estimates were used. If these were overadjusted (<10 events per covariate), the most adjusted estimate without overadjustment was used. Studies using a validated recommended method to define apathy 20 and those using custom measurements were analyzed separately because the apathy construct may differ greatly between these categories. Heterogeneity was assessed using I 2 statistics.
Leave-one-out analyses were performed, in which every study was consecutively excluded once to assess its influence on the overall estimate. Subgroup and sensitivity analyses, including their rationale and whether they were predefined, are listed in eTable 3 in the Supplement. Meta-analyses were conducted in R (R Programming), using the meta and metafor packages.
26,27
Results From 2031 titles and abstracts, 15 studies were selected ( Figure 1 ). Hand searching selected study bibliographies yielded 1 additional study. 28 Thus, 16 studies were included in the final synthesis.
15,22-24,28-39 Table 1 provides an overview of the included studies. Fourteen concerned Western populations, one was a combined international population database, 15 and one was from China.
39
Four populations were derived from screened populationbased cohorts 23,35,38,39 and 12 were from memory clinics. Study populations included SCC (n = 2), 29, 30 MCI (n = 9), 15, 22, 24, [31] [32] [33] [34] [35] 38 amnestic MCI (n = 2), 28,36 cognitive impairment no dementia (n = 1), 23 and mixed patients with no cognitive impairment (NCI) and patients with MCI (n = 2). 37,39 The SCC studies excluded patients with abnormal neuropsychological test scores. Nine studies assessed AD as outcome ( eTable 5 in the Supplement lists study bias assessment scores and eTable 6 in the Supplement provides score motivations. The worst scoring categories were population representativeness, exposure assessment, and follow-up availability. Based on total Newcastle-Ottawa quality assessment scale score, 1 study had a relatively high bias risk 31 and 6 scored worse than average (<7 of 9 points). 29, 31, 33, 34, 37, 38 In studies using a recommended validated definition of apathy, the overall RR for developing dementia for patients with apathy ( Figure 2 ) was 1.81 (95% CI, 1.32-2.50). Heterogeneity was high (I 2 = 76%). The funnel plot suggested low risk of publication bias (eFigure 1 in the Supplement). Leave-one-out a No mean follow-up but assessment for whole cohort at stated time.
b Study assessed both AD and all-cause dementia.
c Mean (minimum-maximum).
d Most adjusted estimate not overadjusted.
e Estimate considered overadjusted (<10 events per predictor).
f Median (interquartile range).
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Discussion
Apathy was consistently associated with an increased risk of incident dementia in patients with MCI and SCC in different settings and countries. However, heterogeneity was considerable. In MCI, the dementia risk was about double for patients with apathy and seemed higher for the short vs the long term, with meta-regression based on follow-up time explaining most heterogeneity. In SCC, the risk for patients with apathy may be as much as 2-fold to more than 7-fold higher, but data were too sparse for a reliable estimate. Results in mixed NCI-MCI populations are difficult to interpret owing to limited data on dementia development in both groups separately. Subgroups of studies adjusting and not adjusting for age and cognition showed similar associations. This may be ecological fallacy. Within studies reporting both crude and adjusted estimates, adjustment for age and cognition increased the association of apathy with dementia, suggesting a stronger association in younger patients who are relatively cognitively intact. Concordantly, HRs seemed higher in SCC compared with MCI. Although usually considered an important confounder, 10 subgroup analyses showed no marked difference between studies including or excluding patients with depression. Apathy HRs seemed higher in studies controlling for depression, suggesting stronger associations in patients without depression, but group sizes were insufficient to allow firm conclusions. Regression with apathy definition type and follow-up duration together explained more than 95% of heterogeneity. Studies using custom apathy definitions found lower estimates. This may be attributable to measurement error, diluting associations. The diminishing association between apathy and dementia with longer follow-up suggests apathy is predominantly prodromal to dementia rather than a causal risk factor 10 ; the risk regressing to the mean over time. However, selective dropout of patients with apathy may also have weakened long-term associations. There were insufficient data to assess the influence of apathy severity, although some studies using the NPI used low (Neuropsychiatric Inventory informant >0) and higher (Neuropsychiatric Inventory questionnaire >0; Neuropsychiatric Inventory informant >2) apathy severity thresholds.
Results 33 Sobow et al, 34 Teng et al 31 Only studies using validated apathy scales are included. FU indicates follow-up; RR, risk ratio.
Research Original Investigation
Association noncensoring could introduce bias, attenuating the association between apathy and dementia. Hazard ratios were therefore the most appropriate summary measure. However, these were unavailable for half of the studies. The different effect measures and the considerable heterogeneity preclude exact estimates of the association between apathy and incident dementia. However, the estimates were overall consistent. Fourth, combining population-based and clinical studies requires some consideration because these populations differ in sample representativeness, prevalence rates, and disease context, potentially influencing associations between apathy and dementia and generalizability. 55 Apathy prevalence and dementia risk estimates were similar in the 2 population-based MCI cohorts compared with memory clinic cohorts. However, inferences regarding mixed MCI-NCI populations are hampered by unclear generalizability and insufficient differentiated data, which may influence combined results. Finally, the value of the subgroup analyses is limited by the relatively small subgroups being easily dominated by single studies and the risk of type 1 error.
Conclusions
In conclusion, apathy was associated with an approximately 2-fold increased risk of dementia in memory clinic patients. The risk seems independent of concurrent depression, greater in the short term compared with the long term, and less strong with higher age and greater cognitive impairment.
Withdrawal from activities and interests in older and/or more cognitively impaired individuals is less specific for underlying neuropathology, perhaps also reflecting changes in lifestyle and physical and mental ability. This suggests apathy is a particularly potent signal in relatively young and otherwise healthy individuals, in whom this behavior change is more easily noticed. Whether apathy, combined with other easily measureable clinical parameters, is a useful predictor on an individual level in clinical practice needs to be investigated in dedicated prognostic studies. The paucity of data on apathy in patients with SCC also warrants more research. Our results concur with findings that symptoms of apathy in community-dwelling older people increase the risk of cognitive decline and incident dementia. 16 (22) A (1) A ( (25) A (1) A (1) A (1) A (1) A (1) A (2) B (1) B (1) 9 Ramakers 2010 (18) A (1) A (1) C (0) A (1) A (1) A (2) A ( (1) A (1) A (1) A (1) B (1) A (1) C (0) 6 Rosenberg 2013 (27) A (1) A (1) A (1) B (0) A (1) A (2) B (1) C (0) 7 Sobow 2014 (28) B (0) A (1) A (1) B (0) A (1) B (1) B (1) B (1) 6 Pink 2015 (29) B (0) A (1) A (1) A (1) A (1) A (2) A (1) B (1) 8 Robert 2008 (30) C (0) A (1) A (1) A (1) A (1) A (2) B (1) B (1) 8 Palmer 2010 (31) C (0) A (1) A (1) A (1) A (1) B (1) B (1) B (1) 7 Peters 2013 (17) C (0) A (1) A (1) A (1) A (1) A (2) B (1) C (0) C: 51% not included in analysis due to incomplete baseline or loss to follow up eTable 6 continued. Detailed bias assessment table based on the Newcastle Ottawa rating scale for observational cohort studies. Studies were scored in according to standardized criteria. For the total score, every category scored A (or B or higher in case of follow up length) was worth one point. The comparability of the cohort on basis of design or analysis could score a maximum of 2 points if both the major confounders of age and cognition were controlled for. NPI: neuropsychiatric inventory, NPI Q: neuropsychiatric inventory Q, MMSE: mini mental state examination, APOE4: apolipoprotein E allele E4, CDR: clinical dementia rating, BMI: body mass index, 3MS: modified mini mental state examination, Hazard Ratio IV, Random, 95% CI eFigure 6. Funnel plot of hazard ratios reported in studies. Only studies using validated recommended apathy scales are included. The left vertical bar represents the fixed effects estimate with 95% confidence intervals. The right vertical bar marks the random effects estimate. The distribution of studies (nearly all higher than the overall random effects estimate, with studies with a lower standard error finding less effects) suggests an overrepresentation of studies reporting a significant association between apathy and dementia incidence. 
